321 related articles for article (PubMed ID: 10959079)
1. Interferon-gamma and interleukin-12 pathway defects and human disease.
Dorman SE; Holland SM
Cytokine Growth Factor Rev; 2000 Dec; 11(4):321-33. PubMed ID: 10959079
[TBL] [Abstract][Full Text] [Related]
2. [Mendelian predisposition to mycobacterial infections in humans].
Casanova JL
J Soc Biol; 2000; 194(1):25-8. PubMed ID: 11107546
[TBL] [Abstract][Full Text] [Related]
3. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.
Lammas DA; Casanova JL; Kumararatne DS
Clin Exp Immunol; 2000 Sep; 121(3):417-25. PubMed ID: 10971505
[No Abstract] [Full Text] [Related]
4. Defects in the interferon-gamma and interleukin-12 pathways.
Rosenzweig SD; Holland SM
Immunol Rev; 2005 Feb; 203():38-47. PubMed ID: 15661020
[TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis].
van Dissel JT; Ottenhoff TH
Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1830-2. PubMed ID: 11020837
[TBL] [Abstract][Full Text] [Related]
6. Genetic heterogeneity of Mendelian susceptibility to mycobacterial infection.
Döffinger R; Altare F; Casanova JL
Microbes Infect; 2000 Nov; 2(13):1553-7. PubMed ID: 11113374
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity.
Holland SM
Immunol Res; 2007; 38(1-3):342-6. PubMed ID: 17917041
[TBL] [Abstract][Full Text] [Related]
8. Mendelian susceptibility to mycobacterial infection in man.
Altare F; Jouanguy E; Lamhamedi S; Döffinger R; Fischer A; Casanova JL
Curr Opin Immunol; 1998 Aug; 10(4):413-7. PubMed ID: 9722917
[TBL] [Abstract][Full Text] [Related]
9. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.
Ottenhoff TH; Verreck FA; Lichtenauer-Kaligis EG; Hoeve MA; Sanal O; van Dissel JT
Nat Genet; 2002 Sep; 32(1):97-105. PubMed ID: 12205477
[TBL] [Abstract][Full Text] [Related]
10. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae.
van de Vosse E; Hoeve MA; Ottenhoff TH
Lancet Infect Dis; 2004 Dec; 4(12):739-49. PubMed ID: 15567123
[TBL] [Abstract][Full Text] [Related]
11. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency.
Lichtenauer-Kaligis EG; de Boer T; Verreck FA; van Voorden S; Hoeve MA; van de Vosse E; Ersoy F; Tezcan I; van Dissel JT; Sanal O; Ottenhoff TH
Eur J Immunol; 2003 Jan; 33(1):59-69. PubMed ID: 12594833
[TBL] [Abstract][Full Text] [Related]
12. [Genetic predisposition to infective diseases in humans. Mendelian predisposition to mycobacterial infections].
Casanova JL
Bull Acad Natl Med; 2000; 184(7):1409-15; discussion 1415-6. PubMed ID: 11261247
[TBL] [Abstract][Full Text] [Related]
13. Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update.
Döffinger R; Dupuis S; Picard C; Fieschi C; Feinberg J; Barcenas-Morales G; Casanova JL
Mol Immunol; 2002 May; 38(12-13):903-9. PubMed ID: 12009568
[TBL] [Abstract][Full Text] [Related]
14. Control of human host immunity to mycobacteria.
Ottenhoff TH; Verreck FA; Hoeve MA; van de Vosse E
Tuberculosis (Edinb); 2005; 85(1-2):53-64. PubMed ID: 15687028
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection.
Elloumi-Zghal H; Barbouche MR; Chemli J; Béjaoui M; Harbi A; Snoussi N; Abdelhak S; Dellagi K
J Infect Dis; 2002 May; 185(10):1468-75. PubMed ID: 11992283
[TBL] [Abstract][Full Text] [Related]
16. The role of interleukin-12 in human infectious diseases: only a faint signature.
Fieschi C; Casanova JL
Eur J Immunol; 2003 Jun; 33(6):1461-4. PubMed ID: 12778462
[TBL] [Abstract][Full Text] [Related]
17. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood.
Remus N; Reichenbach J; Picard C; Rietschel C; Wood P; Lammas D; Kumararatne DS; Casanova JL
Pediatr Res; 2001 Jul; 50(1):8-13. PubMed ID: 11420412
[TBL] [Abstract][Full Text] [Related]
18. [Genetic susceptibility to mycobacterial disease: Mendelian disorders of the interleukin-12 -interferon-gamma axis].
Catherinot E; Fieschi C; Feinberg J; Casanova JL; Couderc LJ
Rev Mal Respir; 2005 Nov; 22(5 Pt 1):767-76. PubMed ID: 16272979
[TBL] [Abstract][Full Text] [Related]
19. Impaired IL-12- and IL-23-Mediated Immunity Due to IL-12Rβ1 Deficiency in Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
Nekooie-Marnany N; Deswarte C; Ostadi V; Bagherpour B; Taleby E; Ganjalikhani-Hakemi M; Le Voyer T; Rahimi H; Rosain J; Pourmoghadas Z; Sheikhbahaei S; Khoshnevisan R; Petersheim D; Kotlarz D; Klein C; Boisson-Dupuis S; Casanova JL; Bustamante J; Sherkat R
J Clin Immunol; 2018 Oct; 38(7):787-793. PubMed ID: 30255293
[TBL] [Abstract][Full Text] [Related]
20. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications.
Fieschi C; Dupuis S; Catherinot E; Feinberg J; Bustamante J; Breiman A; Altare F; Baretto R; Le Deist F; Kayal S; Koch H; Richter D; Brezina M; Aksu G; Wood P; Al-Jumaah S; Raspall M; Da Silva Duarte AJ; Tuerlinckx D; Virelizier JL; Fischer A; Enright A; Bernhöft J; Cleary AM; Vermylen C; Rodriguez-Gallego C; Davies G; Blütters-Sawatzki R; Siegrist CA; Ehlayel MS; Novelli V; Haas WH; Levy J; Freihorst J; Al-Hajjar S; Nadal D; De Moraes Vasconcelos D; Jeppsson O; Kutukculer N; Frecerova K; Caragol I; Lammas D; Kumararatne DS; Abel L; Casanova JL
J Exp Med; 2003 Feb; 197(4):527-35. PubMed ID: 12591909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
